Dr. Raymond (Ray) Hill was previously a member of Addex's Board of Directors from the Annual General Meetings of 2008 until 2012. He is Visiting Professor of Pharmacology at Imperial College London, Chairman/Non-Executive Director of Avilex (Denmark) and a member of the Scientific Advisory Board of Neurosterix. He was previously Chair of the SAB of Asceneuron (2014-2021) and a Non-Executive Director of Orexo AB (2008-2019). Before retirement he was Executive Director, Licensing and External Research at Merck/MSD in Europe (2002-2008) and Executive Director, Pharmacology (1990-2002) at the Merck Neuroscience Research Centre, with oversight of neuroscience research at the Banyu Research Labs in Japan. He is President Emeritus of the British Pharmacological Society and a Fellow of the Academy of Medical Sciences. He received his academic training (BPharm, PhD) at the University of London and an Honorary DSc from the University of Bradford.